Blog yOur Mind

Russia’s Pharmstandard 2008 profit rises 7%

Posted on: April 29, 2009

Reuters – Wednesday, April 29

* Pharmstandard 2008 profit 3.5 bln roubles, up 7 pct

* Sales rise 26 pct to 14.3 bln roubles

* Q1 2009 sales up 38 pct to 4.6 bln roubles

MOSCOW, April 28 – Russian drug maker Pharmstandard <PHSTq.L><PHST.MM> said on Tuesday its 2008 net profit rose by 7 percent to 3.5 billion roubles on the back of growing sales.

The company said in a statement sales rose by 26 percent last year to 14.3 billion roubles. First-quarter 2009 sales were 4.6 billion roubles, up 38 percent year on year.

Earnings before interest, taxes, depreciation and amortisation , excluding foreign exchange loss, grew 24 percent to 6.05 billion roubles, while the EBITDA margin slipped to 42.3 percent, from 42.9 percent in 2007.

Gross profit totalled 8.8 billion roubles, up 28 percent, and gross margin edged up to 61 percent, from 60 percent.

Pharmstandard <PHST.RTS> held an initial public offering in May 2007 raising $880 million through the sale of 43 percent of its equity and becoming the first firm in the sector to float.

The company, which has five plants in Russia, also develops and sells medical equipment and disposable medical products.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 55 other followers




  • 274,382 UFOs
%d bloggers like this: